Study rationale and design of the PEOPLHE trial
- PMID: 38319494
- PMCID: PMC10943160
- DOI: 10.1007/s11547-024-01764-4
Study rationale and design of the PEOPLHE trial
Abstract
Purpose: Lung cancer screening (LCS) by low-dose computed tomography (LDCT) demonstrated a 20-40% reduction in lung cancer mortality. National stakeholders and international scientific societies are increasingly endorsing LCS programs, but translating their benefits into practice is rather challenging. The "Model for Optimized Implementation of Early Lung Cancer Detection: Prospective Evaluation Of Preventive Lung HEalth" (PEOPLHE) is an Italian multicentric LCS program aiming at testing LCS feasibility and implementation within the national healthcare system. PEOPLHE is intended to assess (i) strategies to optimize LCS workflow, (ii) radiological quality assurance, and (iii) the need for dedicated resources, including smoking cessation facilities.
Methods: PEOPLHE aims to recruit 1.500 high-risk individuals across three tertiary general hospitals in three different Italian regions that provide comprehensive services to large populations to explore geographic, demographic, and socioeconomic diversities. Screening by LDCT will target current or former (quitting < 10 years) smokers (> 15 cigarettes/day for > 25 years, or > 10 cigarettes/day for > 30 years) aged 50-75 years. Lung nodules will be volumetric measured and classified by a modified PEOPLHE Lung-RADS 1.1 system. Current smokers will be offered smoking cessation support.
Conclusion: The PEOPLHE program will provide information on strategies for screening enrollment and smoking cessation interventions; administrative, organizational, and radiological needs for performing a state-of-the-art LCS; collateral and incidental findings (both pulmonary and extrapulmonary), contributing to the LCS implementation within national healthcare systems.
Keywords: Low-dose computed tomography; Lung cancer; Lung cancer screening; Lung-RADS; Primary and secondary prevention.
© 2024. The Author(s).
Conflict of interest statement
The authors have no relevant financial or non-financial interests to disclose.
Figures
Similar articles
-
Accelerating integration of tobacco use treatment in the context of lung cancer screening: Relevance and application of implementation science to achieving policy and practice.Transl Behav Med. 2022 Nov 21;12(11):1076-1083. doi: 10.1093/tbm/ibac076. Transl Behav Med. 2022. PMID: 36227937 Free PMC article.
-
Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.AJR Am J Roentgenol. 2021 Apr;216(4):919-926. doi: 10.2214/AJR.20.23637. Epub 2021 Feb 17. AJR Am J Roentgenol. 2021. PMID: 32755178
-
An integrated digital/clinical approach to smoking cessation in lung cancer screening: study protocol for a randomized controlled trial.Trials. 2017 Nov 28;18(1):568. doi: 10.1186/s13063-017-2312-x. Trials. 2017. PMID: 29179734 Free PMC article. Clinical Trial.
-
The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program.Radiographics. 2015 Nov-Dec;35(7):1893-908. doi: 10.1148/rg.2015150079. Epub 2015 Oct 23. Radiographics. 2015. PMID: 26495797 Review.
-
Pairing smoking-cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco.Cancer. 2016 Apr 15;122(8):1150-9. doi: 10.1002/cncr.29926. Epub 2016 Feb 24. Cancer. 2016. PMID: 26916412 Free PMC article. Review.
Cited by
-
Strengthening lung cancer screening in Europe: fostering participation, improving outcomes, and addressing health inequalities through collaborative initiatives in the SOLACE consortium.Insights Imaging. 2024 Oct 22;15(1):252. doi: 10.1186/s13244-024-01814-5. Insights Imaging. 2024. PMID: 39436577 Free PMC article.
References
-
- Allemani C, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075. doi: 10.1016/S0140-6736(17)33326-3. - DOI - PMC - PubMed
-
- Baldwin D et al. (2023) Developing a Pan-European technical standard for a comprehensive high-quality lung cancer CT screening program: an ERS technical standard. Eur Respir J - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
